GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Channel Therapeutics Corp (AMEX:CHRO) » Definitions » FCF Yield %

CHRO (Channel Therapeutics) FCF Yield % : -70.45 (As of Apr. 05, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Channel Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Channel Therapeutics's Trailing 12-Month Free Cash Flow is $-5.79 Mil, and Market Cap is $8.22 Mil. Therefore, Channel Therapeutics's FCF Yield % for today is -70.45%.

The historical rank and industry rank for Channel Therapeutics's FCF Yield % or its related term are showing as below:

CHRO' s FCF Yield % Range Over the Past 10 Years
Min: -70.45   Med: 0   Max: 0
Current: -70.45


CHRO's FCF Yield % is ranked worse than
77.22% of 1497 companies
in the Biotechnology industry
Industry Median: -15.53 vs CHRO: -70.45

Channel Therapeutics's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.


Channel Therapeutics FCF Yield % Historical Data

The historical data trend for Channel Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Channel Therapeutics FCF Yield % Chart

Channel Therapeutics Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
FCF Yield %
- - - - -149.90

Channel Therapeutics Quarterly Data
Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -52.73 -153.62 -17.23 -69.36

Competitive Comparison of Channel Therapeutics's FCF Yield %

For the Biotechnology subindustry, Channel Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Channel Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Channel Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Channel Therapeutics's FCF Yield % falls into.


;
;

Channel Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Channel Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-5.792 / 3.863948
=-149.90%

Channel Therapeutics's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.67 * 4 / 3.863948
=-69.36%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Channel Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Channel Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Channel Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Channel Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
4400 Route 9 South, Suite 1000, Freehold, NJ, USA, 07728
Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.

Channel Therapeutics Headlines